RACGP
US$ 25.18
glp-1 obesity drug news october 9 2025 Weight-Loss Drugs Ride Health, Wellness Wave GLP-1 Agonists: Using Semaglutide, Tirzepatide,
Description
It has to shift priority from nonessential things to more essential things
10.2337/db23-127-OR 77.Wilson JM, Nikooienejad A, Robins DA, et al
However, to date, there is only one randomized clinical trial of GLP-1 RAs (the ELIXA study) evaluating major cardiovascular events as their primary outcomes, and in this study, a neutral cardiovascular effect of lixisenatide was observed in high-risk diabetic subjects
Preliminary data suggests fewer than 30% of patients are still on an AOM after 1 year, with abandonment and discontinuation rates highly sensitive to costs
Will GLP-1 drugs replace bariatric surgery
